MBAI
Check-Cap Ltd.
Healthcare · Diagnostics & Research · NCM
$1.38
Data: 2026-05-15
✓ ETHICAL PASS

MOAT
MODERATE
Data Confidence: 57.1%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$12M
Total market value of the company
2.70
Very cheap relative to earnings
N/A
Based on estimated future earnings — lower means cheaper
Rev Growth
N/A
Year-over-year revenue change
Profit Margin
N/A
How much profit the company keeps from each dollar of revenue
416.7%
Return on equity — how efficiently it uses shareholder money
Analyst Target
N/A
Recommendation
NONE
Consensus view from ? analysts covering this stock
About Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

https://check-cap.com

Country: Israel Industry: Diagnostics & Research
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.1% PASS
Debt must be below 33% of total assets
Cash Ratio
1.7% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKUP
Price trending up with increasing momentum
0.642
Good returns relative to risk taken
0.0671
Suggested allocation is meaningful — the edge justifies a position
-0.168
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-12.7%
Historical annualised return based on price data
-75.2%
Largest peak-to-trough decline — the worst it has been
BEAR
Statistical model detects bearish conditions
Days in State
63
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.72
Less volatile than the market — more defensive
52W High
$3.92
65% below the year high
52W Low
$0.59
133% above the year low
Avg Volume
118,035
Average daily shares traded — higher means easier to buy and sell
1.1
Days it would take all short sellers to cover — higher means more crowded
Short % Float
2.8%
Low short interest — limited bearish positioning
0.0%
Annual dividend as a percentage of the share price
$0.66
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

0.00
Conservative use of debt — low financial risk
0.05
Below 1 means short-term obligations exceed liquid assets — risk flag
Quick Ratio
0.05
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
$846,875
Positive — the business generates more cash than it spends
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
$4M
Profitable — the bottom line is positive
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.